Spondyloarthropathies
Feature
Teamwork guides cardio-rheumatology clinics that care for unique patient population
Cardio-rheumatology programs are “the newest child” in a series of cardiology offshoots focusing on different populations, and such clinics aim to...
Feature
Phil Robinson: Rheumatologist, colleague, huntsman spider rescuer
Philip (“Phil”) Robinson, rheumatologist and associate professor at the University of Queensland and leader of global effort to understand COVID-...
From the Journals
Cardiovascular risk score multipliers suggested for rheumatic diseases
Guidelines could tailor cardiovascular risk scores by using a multiplier of 2.5 for systemic sclerosis, 2.0 for lupus, and 1.5 for any other...
News from the FDA/CDC
FDA approves Idacio as eighth adalimumab biosimilar in U.S.
Data for Idacio (adalimumab-aacf) showed safety, efficacy, and immunogenicity similar to Humira.
From the Journals
Vaccination cuts long COVID risk for rheumatic disease patients
Although it’s possible the higher proportion of Omicron cases in vaccinated patients accounted for lower rates of long COVID, differences in...
From the Journals
Skinny-label biosimilars provide substantial savings to Medicare
The estimated savings to Medicare during 2015-2020 that resulted from competition with five of the first-to-market biosimilars with skinny labels...
Guidelines
New ACR vaccination guideline: Take your best shot
Vaccinate patients with rheumatic and musculoskeletal disease against flu and other vaccine-preventable disease whenever possible, experts say.
Conference Coverage
NSAIDs for spondyloarthritis may affect time to conception
“If a woman is requiring regular NSAIDs for symptom control, the results of this study might encourage me to consider a biologic agent sooner to...
Conference Coverage
Retention rates high after biosimilar-to-biosimilar switch for inflammatory arthritis
Danish investigators studied how a government-mandated switch from one infliximab biosimilar to another affected patients with inflammatory...
From the Journals
Therapeutic drug monitoring pays off for arthritis patients
Patients who reduced their dosage of TNF-alpha inhibitor had less treatment failure and similar risk of adverse events, compared with standard...
From the Journals
Two biologics equally effective for extraintestinal manifestations of IBD
Ustekinumab and vedolizumab have similar effects on extraintestinal manifestations of inflammatory bowel disease, a real-world, retrospective...